Search Results: "Precision Medicine"
-
Precision Medicine Startup Mirador Unveils $400M for R&D of New I&I Drugs
Mirador Therapeutics applies machine learning to human data to discover new immunology and inflammation drugs. The startup’s management includes several from the executive team of Prometheus Biosciences, an immunology biotech bought by Merck last year.
-
MedCity Influencers, Devices & Diagnostics
Pharmacogenomics Offers New Frontier For Precision Medicine
As the industry moves towards more personalized medicine, pharmacogenomics could play a key role in keeping patients healthier longer and in getting them viable treatments for their unique genetic profile.
-
Liquid Biopsy Startup Precede Sets Out to Make Precision Medicine More Precise
Precede Biosciences’ liquid biopsy platform yields insight into the genes and pathways in diseased tissue. Based on Dana-Farber Cancer Institute research, the startup aims to support biopharma drug R&D as it also develops the technology for clinical care applications.
-
MedCity Influencers, Devices & Diagnostics, Artificial Intelligence
AI Can Make Precision Medicine More Accessible to Patients Who Might Not Have Been Able to Benefit in the Past
“Precision medicine” is a term we have heard a lot over the last two decades, […]
-
Achieve Precision Medicine Through AI and Analytics Solutions
MedCity News connected with Integra Connect’s COO, Cory Wiegert at ViVE 2023 to discuss how their new platform will go beyond the “one size fits all” approach to data curation.
-
Merck’s $11B Prometheus Acquisition Brings IBD Drug & Precision Medicine Platform
Merck is acquiring Prometheus Biosciences and a lead drug candidate in development for inflammatory bowel disorders. The deal comes as Merck looks for drug prospects that could make up for revenue declines facing blockbuster seller Keytruda, which faces patent expirations in coming years.
-
Reproductive healthcare is under attack. Precision medicine is more important than ever
The need for precision medicine in the reproductive health care sphere has never been greater: for much of the country, the risks of unwanted pregnancy are exacerbated by abortion legislation and unscientific political rhetoric around birth control.
-
Events, Health IT, Health Tech, sponsored content, Sponsored Post, Startups, Startups
The Latest Events In The Exciting World Of Precision Medicine And Health-Tech Innovations
From May 24-25, come learn about the latest developments and investments in the world of precision medicine and health-teach innovations in these exciting new events in Dubai!
-
MedCity Influencers, Devices & Diagnostics
Precision medicine: A new dimension to improve care outcomes
All the hype around precision medicine can make it seem intimidating and foreign. The good news is that it does not represent a departure from current clinical practice, and it can significantly improve patient care.
-
Scipher Medicine’s blood test shows the benefits of precision medicine in rheumatoid arthritis
The Study to Accelerate Information of Molecular Signatures (AIMS) found RA patients whose treatment was guided by the PrismRA blood test had three times better clinical responses compared to patients that didn’t.
-
MedCity Influencers, BioPharma, Health Tech
In an age of precision medicine, decentralized clinical trials are a valuable tool
ntegrated software, accessible genetic data, and advances in precision medicine can transform the lives of millions of patients–if the clinical trial and larger medical industry embrace these trends.
-
MedCity Influencers, BioPharma
Accelerating the adoption of precision medicine through collaborative efforts across the healthcare industry
While much progress has been made, many patients have molecular drivers of disease that are not detected, interpreted and acted upon with precision therapies, leaving potential life-changing treatments on the table.
-
Pillar Biosciences seeks to make precision medicine a first-line therapy for cancer patients
Randy Pritchard, Pillar Biosciences CEO, highlighted some of the progress the oncology solutions company has made in developing in-vitro diagnostics in response to emailed questions from MedCity News.
-
How hc1 is generating actionable healthcare insights to support precision medicine
At the intersection of health tech and diagnostics, hc1’s CEO Brad Bostic talked about the company’s origins and how it works with medical laboratories, hospitals and health plans.
-
Molecular labs hold the key to evidence-based precision medicine
Molecular testing labs are becoming much more prominent and one reason for their rise is an increased emphasis on evidence-based precision medicine.